Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

P H de Jong; J M Hazes; H K Han; M Huisman; D van Zeben; P A van der Lubbe; A H Gerards; B van Schaeybroeck; P B de Sonnaville; M V van Krugten; J J Luime; A E Weel

doi:10.1136/annrheumdis-2013-204788

Clinical and epidemiological research

Extended report

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

Share this article

Click the icon of the social media platform on which you would like to share this article.

Share This Article:

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Your email: *

Your name: *

Send to: *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

Message subject: (Your Name) has forwarded a page to you from Annals of the Rheumatic Diseases

Message body: (Your Name) thought you would like to see this page from the Annals of the Rheumatic Diseases web site.

Your personal message:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Share this article

Email this article to a friend

Read the full text or download the PDF:

Log in using your username and password